Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non–Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial ...

Cancer clinical trials represent a critical mechanism to advance the fields of hematology and oncology. Every US Food and Drug Administration (FDA)-approved cancer treatment has made its way through ...

We would like to compliment Samnani et al 1 on their insightful evaluation of the impact of the IDEA studies on real-world practice. As requested in the accompanied editorial, 2 we hereby would like ...

This two-arm prospective phase III open-label trial randomly assigns (1:1) participants with low–tumor burden FL who wish to pursue active management to rituximab versus mosunetuzumab (Fig 1), ...

Demographic changes associated with lifestyle changes since the early 1990s have significantly affected the Indian society after economic liberalization. The traditional self-sufficient rural-based ...

Phase Ib Study of BI 836880 (VEGF/Ang2 nanobody) in Combination With Ezabenlimab (anti–PD-1 antibody) in Patients With Advanced or Metastatic Solid Tumors There have been significant advances in ...

Since sorafenib's approval in 2008 for advanced HCC, the landscape of systemic therapy remained largely unchanged for nearly a decade, with no breakthroughs emerging during this period. However, in ...

Leveraging Electronic Health Records to Examine the Real-World Rates of Cancer Genetics Referrals in a Singapore Health Care Cluster Fig 1. Summary of fertility preservation in people with cancer ...

Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non–Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834 In the article that ...

Optimizing Radiotherapy Timing for Nasopharyngeal Carcinoma: The Impact of Radiation Scheduling on Survival FGFRi are effective treatment strategies for patients with advanced solid tumors harboring ...

Clinical Characteristics of Toxicities of Immune Checkpoint Inhibitors and Their Impact on Efficacy in Solid Cancers: An Analysis of Real-World Data in Moroccan Patients The proposed framework ...

Erratum: Surgical Demand and Migratory Patterns: A 10-Year Forecast for Hepatectomy in Oncology in the Northern Region of Brazil The abstract by de Carvalho et al entitled “Regional Patterns of ...